Video Experimental Relacionado
Updated: Jun 26, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Disfunción endotelial nigral, homocisteína y enfermedad de Parkinson
Lancet (London, England)
|July 17, 1999
Resumen
El tratamiento a largo plazo con levodopa para la enfermedad de Parkinson está relacionado con niveles más altos de homocisteína, un marcador de enfermedad vascular. Esto sugiere que la levodopa puede promover problemas cardiovasculares en pacientes con Parkinson.
Área de la Ciencia:
- Neurología Neurología.
- Ciencias Cardiovasculares Ciencias Cardiovasculares
- Farmacología Farmacología.
Sus antecedentes:
- La enfermedad de Parkinson es un trastorno neurodegenerativo que afecta la función motora.
- La levodopa es un tratamiento primario para la enfermedad de Parkinson.
- La enfermedad vascular es una preocupación significativa en la población general.
Objetivo del estudio:
- Para investigar la asociación entre el uso a largo plazo de levodopa y los niveles de homocisteína en pacientes con enfermedad de Parkinson.
- Para determinar si el tratamiento con levodopa influye en los marcadores de enfermedad vascular en la enfermedad de Parkinson.
Principales métodos:
- Comparación de los niveles de homocisteína en pacientes con Parkinson con tratamiento a largo plazo con levodopa.
- Comparación de los niveles de homocisteína en pacientes con Parkinson no tratados previamente.
- Comparando los niveles de homocisteína con controles sanos.
Principales resultados:
- Los pacientes con Parkinson que recibieron levodopa a largo plazo mostraron niveles elevados de homocisteína.
- Los niveles de homocisteína fueron más altos en comparación con los pacientes con Parkinson no tratados y los grupos de control.
- El aumento de homocisteína es un factor de riesgo conocido para la aterosclerosis.
Conclusiones:
- El tratamiento antiparkinsoniano con levodopa puede promover la aparición de enfermedades vasculares en la enfermedad de Parkinson.
- El tratamiento a largo plazo con levodopa podría contribuir al desarrollo de la aterosclerosis en pacientes con Parkinson.
- Se necesitan más investigaciones para explorar los riesgos cardiovasculares asociados con el tratamiento con levodopa.
Videos de Conceptos Relacionados
01:27Protein Import into the Peroxisomes
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
01:22Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
01:30Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...